Presentation THT 2023 Effect of Supersaturated Oxygen (SSO2) on Left Ventricular Ejection Fraction (LVEF) in LAD STEMI Patients Post PCI in the Real World: Retrospective Comparison to Control Patients Presenter: Tyler Bonkowski March 21, 2023
News Conference News THT 2023 TEER or VAD/Transplant in the Advanced HF Patient With MR? Shelley Wood March 20, 2023
News Conference News THT 2023 PCI’s Role for Patients With HFrEF and Extensive CAD: Experts Debate Todd Neale March 20, 2023
Presentation THT 2023 What Are the Pros and Cons of the Win Ratio as the Primary Endpoint for Pivotal Heart Failure Trial Presenter: Mandeep Mehra March 20, 2023
Presentation THT 2023 What are the Strengths and Limitations of a Two-Phase (6-Month Intermediate Endpoints & 12-18 Month Mortality and Heart Failure Hospitalization) Trial Design Presenter: William Abraham March 20, 2023
Presentation THT 2023 How Narrow or Broad Should Trial Enrollment Criteria Be to Achieve Clinically Interpretable Results? (STEMI vs NSTEMI; RV vs. LV vs. LV&RV Shock; AMI-CS vs Chronic HF-CS) Presenter: Gregg Stone March 20, 2023
Presentation THT 2023 Trans-Valvular LV Support: a Glimpse Into the Future Presenter: Colin Hirst March 20, 2023
Presentation THT 2023 Should All ECMO Patients Receive LV Unloading (Include HYPO-ECMO)? Presenter: Dirk Westermann March 20, 2023
Presentation THT 2023 MitraClip for Secondary Mitral Regurgitation with LVEF < 20% Presenter: Brian Whisenant March 20, 2023
Presentation THT 2023 Duration of cf-LVAD Support and Post-Transplant Outcomes Presenter: Jagpreet Grewal March 20, 2023
News Conference News ACC 2023 UK Mini Mitral: No Clear Win for Minimally Invasive MV Repair Todd Neale March 13, 2023
News Conference News ACC 2023 How Dapagliflozin Works in HFpEF: Some Clues From CAMEO-DAPA Todd Neale March 09, 2023
News Conference News ACC 2023 AIMI-HF Misses Mark With Advanced Imaging in Ischemic HFrEF Workup L.A. McKeown March 09, 2023
News Conference News ACC 2023 Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2 Michael O'Riordan March 09, 2023